Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Question

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Dec 07, 2023 3:50pm

133 Views

Post# 35773775

RE:RE:RE:Question

So once again, Beavis, if what you say is true, and the company is so hopeless, why have you been posting here and “invested” for three years?...your argument is stupid and makes no sense whatsoever unless you are literally the dumbest investor on the planet....please don’t reply because I honestly don’t care to hear any more of your worthless bs drivel

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing